-
-
-
[1] Lucendo AJ,Molina-Infante J,Arias Á,et al.Guidelines on eosinophilic esophagitis:evidence-based statements and recommendations for diagnosis and management in children and adults[J].United European Gastroenterol J,2017,5(3):335-358.
[2] Dellon ES,Hirano I.Epidemiology and Natural History of Eosinophilic Esophagitis[J].Gastroenterology,2018,154(2):319-332.
[3] Pilar Navarro ,Angel Arias ,Laura Arias-Gonzlez,et al.Systematic review with meta-analysis:the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies[J].Aliment Pharmacol Ther,2019,49(9):1116-1125.
[4] Sherrill JD,Gao PS,Stucke EM,et al.Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis[J].J Allergy Clin Immunol,2010,126(1):160-165.
[5] Dellon ES,Gibbs WB,Fritchie KJ,et al.Clinical,endoscopic,and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease[J].Clin Gastroenterol Hepatol,2009,7(12):1305-1313.
[6] Taft TH,Kern E,Keefer L,et al.Qualitative assessment of patient-reported outcomes in adults with eosinophilic esophagitis[J].J Clin Gastroenterol,2011,45(9):769-774.
[7] Gomez Torrijos E,Gonzalez-Mendiola R,Alvarado M,et al.Eosinophilic Esophagitis:Review and Update[J].Front Med(Lausanne),2018,5:247.
[8] Molina-Infante J,Bredenoord AJ,Cheng E,et al.Proton pump inhibitor-responsive oesophageal eosinophilia:an entity challenging current diagnostic criteria for eosinophilic oesophagitis[J].Gut,2016,65(3):524-531.
[9] Kim HP,Dellon ES.An Evolving Approach to the Diagnosis of Eosinophilic Esophagitis[J].Gastroenterol Hepatol(N Y),2018,14(6):358-366.
[10] Lucendo AJ,Arias Á,Molina-Infante J.Efficacy of Proton Pump Inhibitor Drugs for Inducing Clinical and Histologic Remission in Patients With Symptomatic Esophageal Eosinophilia:A Systematic Review and Meta-Analysis[J].Clin Gastroenterol Hepatol,2016,14(1):13-22.
[11] Molina-Infante J,Rodriguez-Sanchez J,Martinek J,et al.Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis[J].Am J Gastroenterol,2015,110(11):1567-1575.
[12] 李敬华,胡建华,张丽颖,等.唐旭东通降法治疗胃食管反流病经验[J].中医杂志,2012,53(20):1779-1780.
[13] 唐旭东.董建华“通降论”学术思想整理[J].北京中医药大学学报,1995,2:45-48.
[14] Harris RF,Menard-Katcher C,Atkins D,et al.Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis[J].J Pediatr Gastroenterol Nutr,2013,57(4):500-505.
[15] Van Rhijn BD,Weijenborg PW,Verheij J,et al.Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis[J].Clin Gastroenterol Hepatol,2014,12(11):1815-1823.
[16] 唐旭东,马祥雪.传承董建华“通降论”学术思想,创建脾胃病辨证新八纲[J].中国中西医结合消化杂志,2018,26(11):893-896.
-
计量
- 文章访问数: 216
- PDF下载数: 413
- 施引文献: 0
下载: